Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

ACHV Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Achieve Life Sciences, Inc.NASDAQ: ACHV

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 53.38M shares rose 53.9% year over year, ahead of the +39.5% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +60.3% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +53.9% holds above the trailing-twelve-month pace of +39.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
53.38M+0.2% QoQ
Last fiscal yearDec 2025
43.59M+35.9% YoY
LTMMar 2026
48.09M+39.5% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+53.9%——
1 year+35.9%——
3-year CAGR+60.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
43.59M USD
Year-over-year change
+35.9%
4-year CAGR
+52.2%

Weighted Avg Shares (Diluted) vs competitors

How ACHV compares with its peers on the latest reported figures

No competitor Weighted Avg Shares (Diluted) figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue000229K228K
Gross Profit000(229K)(228K)
Gross Margin—————
Research & Development23.97M30.08M15.81M22.82M22.96M
Selling, General & Admin9.13M10.72M11.44M16.25M31.87M
Operating Expenses33.09M40.8M27.25M38.84M54.65M
Depreciation & Amortization250K236K228K229K228K
EBITDA(32.9M)(40.33M)(26.73M)(37.42M)(53.6M)
EBITDA Margin—————
Operating Income(33.09M)(40.8M)(27.25M)(39.07M)(54.88M)
Operating Margin—————
Interest Income17K199K825K2.36M1.5M
Interest Expense01.79M2.85M2.18M819K
Other Income / Expenses(58K)(1.55M)(2.57M)(758K)232K
Income Before Tax(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Net Margin—————
EPS (Basic)(4.05)(3.95)(1.50)(1.24)(1.25)
EPS (Diluted)(4.05)(3.95)(1.50)(1.24)(1.25)
Weighted Avg Shares8.12M10.59M19.83M32.07M43.59M
Weighted Avg Shares (Diluted)8.12M10.59M19.83M32.07M43.59M

Achieve Life Sciences, Inc.

NASDAQ:ACHV

Intrinsic Alpha fair value

Locked

Current Price

$6.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.